Obesity and Its Systemic Effects

Category: Health | Vida Vertical

Summary

The prevalence of overweight and obesity has risen substantially in industrialised countries. In Germany, more than half of adults have a body mass index (BMI) above the normal-weight range. This article examines diagnostic measures and their limitations and considers cardiovascular, metabolic and musculoskeletal consequences of obesity. It concludes by discussing how hydroponic and aquaponic cultivation can improve access to high-volume, nutrient-rich plant foods and suitable protein sources as part of a broader prevention strategy.

1. Introduction: the epidemiological scale of obesity

The modern food and activity environment has contributed to marked changes in population body composition. Data from the Robert Koch Institute and World Health Organization indicate that more than half of adults in Germany are classified as overweight or obese by BMI. This is not merely a cosmetic issue: obesity is a chronic disease and an important public-health challenge associated with many other conditions.

2. Diagnostic measures and their limitations

2.1 Body mass index (BMI)

BMI relates body weight to height squared. The WHO classifies 18.5–24.9 as the normal range for most adults, 25.0–29.9 as overweight and 30 or above as obesity, subdivided into classes I, II and III. Different considerations may apply to some populations and clinical contexts.

2.2 Limitations of BMI and visceral adiposity

BMI is a useful population measure but has important limitations for individuals. It does not distinguish fat mass from muscle, bone or body water. A highly trained athlete may be classified as overweight because of muscle mass, while a person with a BMI in the normal range can still have excess visceral fat and metabolic risk.

Fat distribution adds clinically useful information. Visceral fat around internal organs is metabolically active and associated with inflammation and cardiometabolic risk. Waist circumference is therefore a useful additional measure. Common European thresholds identify increased risk from 80 cm in women and 94 cm in men, but risk varies with sex, ancestry and other factors. Bioelectrical impedance can estimate body composition, though accuracy depends on device and measurement conditions.

3. Pathophysiological consequences of obesity

Obesity can affect almost every organ system through interacting mechanical, metabolic, hormonal and inflammatory pathways:

3.1 Cardiovascular disease

• Arterial hypertension:Excess adiposity contributes to hypertension through mechanisms including renal sodium handling, neurohormonal activation, vascular dysfunction and increased haemodynamic demand. The proportion attributable to obesity varies among populations and cannot be reduced to body mass alone.
• Atherosclerosis:Dyslipidaemia, hypertension, insulin resistance, inflammation and other factors often cluster with obesity and contribute to atherosclerosis. Plaque formation and loss of vascular function increase the risk of myocardial infarction and ischaemic stroke.

3.2 Metabolic syndrome and type 2 diabetes

Obesity, particularly visceral adiposity, is a major modifiable risk factor for type 2 diabetes, but it is not the sole direct cause. Excess fatty acids, ectopic fat, inflammation and genetic susceptibility can impair insulin signalling. The pancreas initially compensates by producing more insulin; beta-cell function may later decline and persistent hyperglycaemia can develop.

3.3 Musculoskeletal and structural effects

Higher body mass increases mechanical loading on joints and can contribute to pain, altered movement and osteoarthritis, especially in the knees and hips. Outcomes are not inevitable: anatomy, muscle strength, activity, previous injury and inflammatory factors also influence risk.

3.4 Mortality and cancer risk

Severe obesity is associated with reduced life expectancy, although individual effects vary with age, health, fitness and access to care. Excess body fat is also associated with increased risk of several cancers through hormonal, metabolic and inflammatory pathways; there is no single universal percentage increase across all malignancies.

4. Relevance to Vida Vertical: prevention through hydroponic and aquaponic systems

As a specialist in aquaponics and hydroponics, I view obesity not as a failure of willpower but as a complex disease shaped by biological, social and environmental factors. An obesogenic environment makes energy-dense, highly processed foods easy to obtain while limiting healthier choices. Controlled home growing can support several practical responses:

1. High-volume, nutrient-rich plant foodsHydroponic leafy vegetables, microgreens and brassicas such as broccoli and kale have low energy density and high water content. They can increase meal volume and fibre and support satiety. Intact plant structure may slow eating and digestion and moderate glycaemic response, but it does not guarantee the prevention of cravings or insulin peaks.

2. Protein and aquaponicsProtein generally promotes satiety and has a higher thermic effect than carbohydrate or fat. Fish raised in well-managed aquaponic systems can provide high-quality protein and, depending on species and feed, omega-3 fatty acids. Adequate protein and resistance exercise help preserve lean mass during weight loss. Muscle contributes to energy expenditure, but preserving it does not by itself prevent weight regain.

3. Prebiotic fibre and the gut microbiomePlant foods provide diverse fibres fermented by gut microorganisms, some of which produce short-chain fatty acids such as butyrate. These metabolites interact with the gut barrier, immune system and metabolism. The microbiome is one part of obesity physiology, and effects vary by diet and individual.

4. Reshaping the food environmentGrowing food at home can increase availability of minimally processed Group 1 foods and reduce reliance on products containing added sugars, refined fats or certain additives. It may support food skills and more attentive eating, but claims that it “recalibrates” dopamine or restores intuitive satiety are not established and should not replace evidence-based obesity care.

5. Conclusion

Obesity is a complex chronic disease that extends beyond body weight and can affect cardiovascular, metabolic and musculoskeletal health. Treatment and prevention require more than calorie restriction alone and should address food quality, activity, sleep, psychological wellbeing, medication where appropriate and the wider environment.

Urban hydroponic and aquaponic cultivation can make fibre-rich vegetables and suitable protein foods more accessible. It can support, but does not replace, professional assessment or a comprehensive treatment plan. Prevention works best when healthy options become practical, safe and sustainable.

Note: This article provides general scientific information and does not replace medical diagnosis or treatment. Anyone living with obesity or metabolic disease, or planning a new exercise or dietary programme, should consult an appropriately qualified healthcare professional.

References:

• Robert Koch Institute (RKI). (2021). Overweight and obesity among adults in Germany. Journal of Health Monitoring.
• World Health Organization (WHO). (2021). Obesity and overweight. Fact sheets.
• German Obesity Society (DAG). (2022). Guidelines for the prevention and treatment of obesity.
• German Nutrition Society (DGE). (2023). D-A-CH reference values for nutrient intake.
• Hall, K. D., et al. (2019). Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain. Cell Metabolism, 30(1), 67-77.

Author: Uwe | Vida Vertical – Health